Sheng Cai Selected Research

Sheng Cai Research Topics

Disease

9	Neoplasms (Cancer) 05/2024 - 01/2014
2	Infections 04/2024 - 09/2023
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2023 - 03/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 03/2021
2	Hepatocellular Carcinoma (Hepatoma) 03/2021 - 01/2012
2	Carcinoma (Carcinomatosis) 10/2015 - 01/2012
1	Papillary Thyroid Cancer 04/2024
1	Lung Neoplasms (Lung Cancer) 03/2022
1	Cataract (Cataracts) 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 01/2022
1	Carcinogenesis 01/2022
1	Graves Disease (Basedow Disease) 01/2022
1	Parathyroid Diseases (Parathyroid Disorders) 09/2021
1	Thyroid Nodule (Nodule, Thyroid) 09/2021
1	Primary Hyperparathyroidism 09/2021
1	Thyroid Neoplasms (Thyroid Cancer) 09/2021
1	Multiple Endocrine Neoplasia Type 1 09/2021
1	Triple Negative Breast Neoplasms 03/2021
1	Adenocarcinoma 03/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021
1	Retinoblastoma (Glioblastoma, Retinal) 03/2021
1	Osteosarcoma (Osteogenic Sarcoma) 03/2021
1	COVID-19 01/2021
1	Starvation 07/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2019
1	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2019
1	Rheumatoid Arthritis 10/2019
1	Hypercholesterolemia 03/2018
1	Proteinuria 03/2018
1	Liver Neoplasms (Liver Cancer) 01/2014
1	Tuberculosis (Tuberculoses) 04/2013
1	Leiomyoma (Uterine Fibroids) 02/2013
1	Fibromuscular Dysplasia 04/2007
1	Takayasu Arteritis (Arteritis, Takayasu's) 04/2007
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 05/2006

Drug/Important Bio-Agent (IBA)

4	MicroRNAs (MicroRNA)IBA 05/2024 - 08/2019
3	Biomarkers (Surrogate Marker)IBA 05/2024 - 10/2019
2	Proteins (Proteins, Gene)FDA Link 09/2023 - 05/2006
1	Catalytic DNA (Deoxyribozyme)IBA 04/2024
1	Arginine (L-Arginine)FDA Link 04/2024
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 04/2024
1	Serine (L-Serine)FDA Link 04/2024
1	Circulating Tumor DNAIBA 10/2023
1	DNA (Deoxyribonucleic Acid)IBA 10/2023
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 09/2023
1	Mucin-1 (CA 15-3 Antigen)IBA 03/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Secretory Immunoglobulin A (SIgA)IBA 01/2022
1	Vinblastine (Vinblastine Sulfate)FDA Link 03/2021
1	Pemetrexed (MTA)FDA Link 03/2021
1	Docetaxel (Taxotere)FDA Link 03/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2021
1	Temozolomide (Temodar)FDA LinkGeneric 03/2021
1	Circular RNAIBA 03/2021
1	delta proteinIBA 03/2021
1	Adenosine Triphosphate (ATP)IBA 03/2021
1	Cisplatin (Platino)FDA LinkGeneric 03/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2021
1	3' Untranslated Regions (3' UTR)IBA 03/2021
1	Fluorouracil (Carac)FDA LinkGeneric 03/2021
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 03/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2021
1	Methotrexate (Mexate)FDA LinkGeneric 03/2021
1	Vincristine (Oncovin)FDA LinkGeneric 03/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Nucleic AcidsIBA 11/2020
1	Phosphate Transport Proteins (Phosphate Transporter)IBA 07/2020
1	Connective Tissue Growth FactorIBA 10/2019
1	CreatinineIBA 03/2018
1	PlatinumIBA 10/2015
1	Platinum Compounds (Compounds, Platinum)IBA 10/2015
1	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 01/2014
1	Small Interfering RNA (siRNA)IBA 01/2014
1	Thioredoxin-Disulfide ReductaseIBA 04/2013
1	ThioredoxinsIBA 04/2013
1	Insulin (Novolin)FDA Link 01/2012
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2012
1	p38 Mitogen-Activated Protein KinasesIBA 01/2012
1	N 30IBA 04/2007
1	Exonucleases (3' 5' Exonuclease)IBA 05/2006

Therapy/Procedure

2	Therapeutics 03/2021 - 01/2014
1	Parathyroidectomy 09/2021
1	Thyroidectomy 09/2021
1	Hysterectomy 02/2013